Pearson v. Shalala
This article was originally published in The Tan Sheet
Executive Summary
Five House members praise FDA for its progress in implementing the court decision in a Nov. 9 letter to Commissioner Jane Henney, MD. Reps. Ron Paul, MD, (R-Tex.), Helen Chenoweth-Hage (R-Idaho), Peter DeFazio (D-Ore.), John Hostettler (R-Ind.) and Bob Stump (R-Ariz.) note, "We are particularly pleased by the FDA's interest in allowing the use of disclaimers for statements that, while not approved by the FDA, are not inherently misleading." The congressmen also state they are "pleased that the FDA is committed to establishing clear scientific standards for reviewing health claims" for dietary supplements, adding they will "continue to closely monitor" the agency's "progress on this issue." In an Oct. 5 letter, FDA agreed it would reopen the comment period on the four relevant health claims after issuing its guidance on "significant scientific agreement" (1"The Tan Sheet" Oct. 18, In Brief)